XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock Issued
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Balances at Dec. 31, 2018 $ 313,376 $ 0 $ 141,842 $ (795,821) $ 190,597 $ 1,298,752 $ 21,429 $ (567,107) $ (21,429) $ 45,113
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 512,218         503,919       8,299
Cash dividends declared:                    
Noncontrolling interests (4,693)                 (4,693)
Total other comprehensive income (loss) (58)             914   (972)
Sale of investment in consolidated subsidiary 4,026                 4,026
Strategic venture exit (3,694)                 (3,694)
Stock appreciation rights exercised (117)   20 (117) (20)          
Vesting of restricted stock units and other stock grants (2,882)   402 (2,882) (402)          
Vesting of performance share units (8,248)   1,136 (8,235) (1,149)          
Treasury shares repurchased (31,838)     (31,838)            
Amortization of unearned stock-based compensation, net of forfeitures 11,569       11,569          
Balances at Dec. 31, 2019 789,659   143,400 (838,893) 200,595 1,824,100   (587,622)   48,079
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (21,975)         (26,341)       4,366
Cash dividends declared:                    
Noncontrolling interests (2,978)                 (2,978)
Total other comprehensive income (loss) (55,307)             (58,119)   2,812
Purchase of noncontrolling interest (561)       (4,527)         3,966
Stock appreciation rights exercised (24)   11 (24) (11)          
Vesting of restricted stock units and other stock grants (1,108)   288 (1,108) (288)          
Vesting of performance share units (3,205)   589 (3,205) (589)          
Amortization of unearned stock-based compensation, net of forfeitures 8,898       8,898          
Balances at Dec. 31, 2020 713,399   144,288 (843,230) 204,078 1,797,759   (645,741)   56,245
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 2,729         (3,249)       5,978
Cash dividends declared:                    
Noncontrolling interests (3,116)                 (3,116)
Total other comprehensive income (loss) 84,105             85,602   (1,497)
Stock appreciation rights exercised (376)   58 (376) (58)          
Vesting of restricted stock units and other stock grants (1,983)   382 (1,983) (382)          
Vesting of performance share units (1,033)   155 (1,033) (155)          
Amortization of unearned stock-based compensation, net of forfeitures 12,045       12,045          
Balances at Dec. 31, 2021 $ 805,770   $ 144,883 $ (846,622) $ 215,528 $ 1,794,510   $ (560,139)   $ 57,610